What is Acadia Pharmaceuticals's net debt / EBITDA?

Acadia Pharmaceuticals (ACAD) reported net debt / EBITDA of -2.5× in Q1 2026.

How has Acadia Pharmaceuticals's net debt / EBITDA changed year-over-year?

Acadia Pharmaceuticals's net debt / EBITDA decreased by 283.1% year-over-year, from -0.7× to -2.5×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Acadia Pharmaceuticals ACAD Net debt / EBITDA

Net debt / EBITDA at other companies

BiogenBIIB

1.2×+0.3×

Neurocrine BiosciencesNBIX

0.2×-0.3×

Catalyst PharmaceuticalCPRX

-2.5×+0.4×

PTC TherapeuticsPTCT

-7.3×-9.8×

TG TherapeuticsTGTX

2.1×+0.1×

Arrowhead ResearchARWR

-0.3×—

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

net debt/ebitda=-2.5×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's net debt / EBITDA?: Acadia Pharmaceuticals (ACAD) reported net debt / EBITDA of -2.5× in Q1 2026.
How has Acadia Pharmaceuticals's net debt / EBITDA changed year-over-year?: Acadia Pharmaceuticals's net debt / EBITDA decreased by 283.1% year-over-year, from -0.7× to -2.5×.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.